IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intercept Pharmaceuticals in

CUSIP: 45845PAA6 | 131 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Oaktree Capital Management LP9,506,000
0.1% of portfolio›$9.6M
UBS Asset Management Americas LLC200,000
0.0% of portfolio›$198.5K
Congress Wealth Management LLC / de /10,000
0.0% of portfolio›$10.0K
Wedbush Securities Inc3,000
0.0% of portfolio›$300
StyleTurnoverLocationFiled
Oaktree Capital Management LP
9,506,000$9.6M0.1%YieldMediumLos Angeles, CA2023-08-14
UBS Asset Management Americas LLC
200,000$198.5K0.0%GrowthLowNew York, NY2023-08-11
Congress Wealth Management LLC / de /
10,000$10.0K0.0%N/AN/ABoston, MA2023-07-13
Wedbush Securities Inc
3,000$3000.0%CoreLowPasadena, CA2023-08-14